For example, the use of electron transport chain inhibitors to treat MM resulted in the upregulation of the cysteine glutamate reverse transporter SLC7A11 in MM, thereby reducing mitochondrial stress-induced proteasome inhibitor resistance [48, 49]. Here, SLC7A11 is linked to Miyoshi myopathy.